{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:13:23Z","timestamp":1783354403448,"version":"3.54.6"},"reference-count":139,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.drugpo.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T23:13:02Z","timestamp":1437088382000},"page":"899-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Enhancing the detection and management of acute hepatitis C virus infection"],"prefix":"10.1016","volume":"26","author":[{"given":"Marianne","family":"Martinello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2015.07.003_bib0005","series-title":"Recommendations for testing, managing, and treating hepatitis C","author":"AASLD\/IDSA\/IAS\u2013USA","year":"2014"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0010","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.22534","article-title":"High incidence of hepatitis C virus reinfection in a cohort of injecting drug users","volume":"48","author":"Aitken","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.drugpo.2012.07.006","article-title":"Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland","volume":"23","author":"Allen","year":"2012","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jmv.23293","article-title":"Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients","volume":"84","author":"Anggorowati","year":"2012","journal-title":"Journal of Medical Virology"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/JCM.01064-10","article-title":"Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins","volume":"49","author":"Araujo","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States","volume":"31","author":"Armstrong","year":"2000","journal-title":"Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2015.07.003_bib0035","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of hepatitis C virus infection among people who are actively injecting drugs: A systematic review and meta-analysis","volume":"57","author":"Aspinall","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1016\/j.drugpo.2015.07.003_bib0040","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2893.2010.01400.x","article-title":"Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program","volume":"18","author":"Blome","year":"2011","journal-title":"Journal of Viral Hepatitis"},{"issue":"11","key":"10.1016\/j.drugpo.2015.07.003_bib0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jvh.12272","article-title":"Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection","volume":"21","author":"Boesecke","year":"2014","journal-title":"Journal of Viral Hepatitis"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jhep.2004.11.018","article-title":"Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C","volume":"42","author":"Broers","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0055","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cit938","article-title":"Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: A longitudinal study","volume":"58","author":"Bruneau","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2893.2006.00802.x","article-title":"A short course of pegylated interferon-alpha in acute HCV hepatitis","volume":"14","author":"Calleri","year":"2007","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0065","first-page":"1457","article-title":"Notes from the Field: Risk factors for hepatitis C virus infections among young adults \u2013 Massachusetts, 2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"28","key":"10.1016\/j.drugpo.2015.07.003_bib0070","first-page":"945","article-title":"Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men \u2013 New York City, 2005\u20132010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0075","first-page":"358","article-title":"Notes from the field: Hepatitis C virus infections among young adults \u2013 rural Wisconsin, 2010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0080","series-title":"Viral Hepatitis Surveillance \u2013 United States 2012","author":"Centers for Disease Control and Prevention","year":"2012"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3350\/cmh.2014.20.4.368","article-title":"Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection","volume":"20","author":"Cho","year":"2014","journal-title":"Clinical and Molecular Hepatology"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11524-009-9417-9","article-title":"Prevalence and incidence of HCV Infection among Vietnam heroin users with recent onset of injection","volume":"87","author":"Clatts","year":"2010","journal-title":"Journal of Urban Health: Bulletin of the New York Academy of Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2893.2009.01167.x","article-title":"Early treatment improves outcomes in acute hepatitis C virus infection: A meta-analysis","volume":"17","author":"Corey","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drugpo.2010.10.007","article-title":"Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review","volume":"22","author":"Corson","year":"2011","journal-title":"International Journal of Drug Policy"},{"issue":"9","key":"10.1016\/j.drugpo.2015.07.003_bib0105","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S095026880900212X","article-title":"Incidence of hepatitis C in drug injectors: The role of homelessness, opiate substitution treatment, equipment sharing, and community size","volume":"137","author":"Craine","year":"2009","journal-title":"Epidemiology and Infection"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cid\/ciu782","article-title":"Hepatitis C core antigen testing: A reliable, quick, and potentially cost-effective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection","volume":"60","author":"Cresswell","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2015.07.003_bib0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2007.09.011","article-title":"A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus","volume":"93","author":"Currie","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1155\/2009\/912848","article-title":"Spontaneous clearance of hepatitis C after liver and renal transplantation","volume":"23","author":"Dale","year":"2009","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.003_bib0125","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/QAD.0b013e3281053a0c","article-title":"Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours","volume":"21","author":"Danta","year":"2007","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1086\/520660","article-title":"Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users","volume":"45","author":"De Rosa","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dki458","article-title":"Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C","volume":"57","author":"De Rosa","year":"2006","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2004.02023.x","article-title":"Treatment of acute hepatitis C with interferon \u03b1-2b: Early initiation of treatment is the most effective predictive factor of sustained viral response","volume":"20","author":"Delwaide","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1473-3099(13)70059-8","article-title":"Delayed versus immediate treatment for patients with acute hepatitis C: A randomised controlled non-inferiority trial","volume":"13","author":"Deterding","year":"2013","journal-title":"Lancet Infectious Diseases"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2012.05.044","article-title":"Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C","volume":"143","author":"Dill","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ197","article-title":"Hepatitis C virus therapeutic development: In pursuit of \u201cPerfectovir\u201d","author":"Dore","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2009.09.019","article-title":"Effective treatment of injecting drug users with recently acquired hepatitis C virus infection","volume":"138","author":"Dore","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0165","series-title":"Low rates of re-infection and reduced injecting long-term following recently acquired HCV in the Australian trial of acute hepatitis C: The ATAHC recall study","author":"Doyle","year":"2014"},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2015.07.003_bib0170","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/427441","article-title":"Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users","volume":"40","author":"Edlin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0b013e328343443b","article-title":"Acute hepatitis C in HIV-infected individuals: Recommendations from the European AIDS Treatment Network (NEAT) consensus conference","volume":"25","author":"European Aids Treatment Network Acute Hepatitis C. Infection Consensus Panel","year":"2011","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: Management of hepatitis C virus infection","volume":"60","author":"European Association for Study of Liver","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0190","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cit799","article-title":"Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men","volume":"58","author":"Fierer","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(14)60064-7","article-title":"Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C following liver transplantation","author":"Forns","year":"2014","journal-title":"Hepatology"},{"issue":"4 Pt 1","key":"10.1016\/j.drugpo.2015.07.003_bib0200","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-11-39","article-title":"Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: A cohort study","volume":"11","author":"Gamage","year":"2011","journal-title":"BMC Infectious Diseases"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0210","first-page":"115","article-title":"Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001\u20132004","volume":"10","author":"Gambotti","year":"2005","journal-title":"Euro Surveillance"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0215","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0031-1297922","article-title":"What is killing people with hepatitis C virus infection?","volume":"31","author":"Grebely","year":"2011","journal-title":"Seminars in Liver Disease"},{"issue":"13","key":"10.1016\/j.drugpo.2015.07.003_bib0225","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/QAD.0b013e3283553719","article-title":"Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV\/HIV co-infection","volume":"26","author":"Grebely","year":"2012","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0230","doi-asserted-by":"crossref","first-page":"e97726","DOI":"10.1371\/journal.pone.0097726","article-title":"Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996\u20132012","volume":"9","author":"Grebely","year":"2014","journal-title":"PLOS ONE"},{"issue":"12","key":"10.1016\/j.drugpo.2015.07.003_bib0235","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2893.2009.01256.x","article-title":"Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection","volume":"17","author":"Grebely","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0245","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.24754","article-title":"Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection","volume":"55","author":"Grebely","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.drugpo.2015.07.003_bib0250","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.transproceed.2012.07.074","article-title":"Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: Prospective study","volume":"44","author":"Gutierrez-Moreno","year":"2012","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.003_bib0255","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"American Journal of Epidemiology"},{"issue":"11","key":"10.1016\/j.drugpo.2015.07.003_bib0260","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/345554","article-title":"Hepatitis C virus seroconversion among young injection drug users: Relationships and risks","volume":"186","author":"Hahn","year":"2002","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0265","doi-asserted-by":"crossref","first-page":"e0122232","DOI":"10.1371\/journal.pone.0122232","article-title":"Patterns of hepatitis C virus RNA levels during acute infection: The InC3 study","volume":"10","author":"Hajarizadeh","year":"2015","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.003_bib0270","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/jmv.24010","article-title":"Dynamics of HCV RNA levels during acute hepatitis C virus infection","volume":"86","author":"Hajarizadeh","year":"2014","journal-title":"Journal of Medical Virology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0275","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2012.07.007","article-title":"Case definitions for acute hepatitis C virus infection: A systematic review","volume":"57","author":"Hajarizadeh","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"9","key":"10.1016\/j.drugpo.2015.07.003_bib0280","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0285","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/1471-2458-14-645","article-title":"Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs","volume":"14","author":"Hayes","year":"2014","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0290","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2013.04.035","article-title":"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) \u2013 NCT01514890","volume":"59","author":"Hezode","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0295","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2893.2007.00937.x","article-title":"Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: A cluster randomized controlled trial","volume":"15","author":"Hickman","year":"2008","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0300","series-title":"Risk of late relapse or re-infection with hepatitis C after sustained virological response: Meta-analysis of 66 studies in 11,071 patients","author":"Hill","year":"2015"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0305","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","article-title":"Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots","volume":"18","author":"Hope","year":"2011","journal-title":"Journal of Viral Hepatitis"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0310","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/hiv.12127","article-title":"Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: No influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance","volume":"15","author":"Ingiliz","year":"2014","journal-title":"HIV Medicine"},{"issue":"20","key":"10.1016\/j.drugpo.2015.07.003_bib0315","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","article-title":"Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options","volume":"368","author":"Jacobson","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1016\/j.drugpo.2015.07.003_bib0320","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0325","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/eurpub\/ckt156","article-title":"Effectiveness of interventions to increase hepatitis C testing uptake among high-risk groups: A systematic review","volume":"24","author":"Jones","year":"2014","journal-title":"The European Journal of Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0330","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jmv.2066","article-title":"Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use","volume":"65","author":"Kalinina","year":"2001","journal-title":"Journal of Medical Virology"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0335","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1572-0241.2008.01825.x","article-title":"Acute hepatitis C: A systematic review","volume":"103","author":"Kamal","year":"2008","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0340","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","article-title":"Peginterferon alfa-2b therapy in acute hepatitis C: Impact of onset of therapy on sustained virologic response","volume":"130","author":"Kamal","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0345","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/hep.20266","article-title":"Pegylated interferon alpha therapy in acute hepatitis C: Relation to hepatitis C virus-specific T cell response kinetics","volume":"39","author":"Kamal","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0350","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of peginterferon therapy in acute hepatitis C: A randomized trial","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0355","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/hep.26113","article-title":"A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0360","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2105\/AJPH.2013.301601","article-title":"Estimating acute viral hepatitis infections from nationally reported cases","volume":"104","author":"Klevens","year":"2014","journal-title":"American Journal of Public Health"},{"issue":"17","key":"10.1016\/j.drugpo.2015.07.003_bib0365","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM","volume":"25","author":"Lambers","year":"2011","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0370","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"issue":"9916","key":"10.1016\/j.drugpo.2015.07.003_bib0375","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(13)62121-2","article-title":"Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): An open-label, randomised, phase 2 trial","volume":"383","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0380","doi-asserted-by":"crossref","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis C incidence in Australian prisoners","author":"Luciani","year":"2014","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.003_bib0385","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/MEG.0000000000000121","article-title":"Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease","volume":"26","author":"Maasoumy","year":"2014","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.003_bib0390","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0395","doi-asserted-by":"crossref","first-page":"e90560","DOI":"10.1371\/journal.pone.0090560","article-title":"Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period","volume":"9","author":"Marco","year":"2014","journal-title":"PLOS ONE"},{"issue":"8.","key":"10.1016\/j.drugpo.2015.07.003_bib0400","article-title":"Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons","volume":"3","author":"Martin","year":"2013","journal-title":"BMJ Open"},{"issue":"16","key":"10.1016\/j.drugpo.2015.07.003_bib0405","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/QAD.0b013e32836381cc","article-title":"Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM","volume":"27","author":"Martin","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0410","first-page":"661a","article-title":"Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II Study","volume":"60","author":"Martinello","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0415","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/cid\/ciq200","article-title":"Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C","volume":"52","author":"Matthews","year":"2011","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0420","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.drugpo.2012.02.003","article-title":"Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow","volume":"23","author":"McDonald","year":"2012","journal-title":"International Journal of Drug Policy"},{"issue":"7","key":"10.1016\/j.drugpo.2015.07.003_bib0425","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/605561","article-title":"Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria","volume":"49","author":"McGovern","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0430","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jcv.2011.05.003","article-title":"Hepatitis C virus core antigen: Analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay","volume":"51","author":"Medici","year":"2011","journal-title":"Journal of Clinical Virology"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0435","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/infdis\/jiq112","article-title":"Changes in blood-borne infection risk among injection drug users","volume":"203","author":"Mehta","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"9316","key":"10.1016\/j.drugpo.2015.07.003_bib0440","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0445","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"Journal of Viral Hepatitis"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0450","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2893.2006.00812.x","article-title":"High incidence of hepatitis C virus reinfection within a cohort of injecting drug users","volume":"14","author":"Micallef","year":"2007","journal-title":"Journal of Viral Hepatitis"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0455","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0460","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7326\/0003-4819-159-5-201309030-00672","article-title":"Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2458-9-34","article-title":"HCV-related burden of disease in Europe: A systematic assessment of incidence, prevalence, morbidity, and mortality","volume":"9","author":"Muhlberger","year":"2009","journal-title":"BMC Public Health"},{"issue":"9791","key":"10.1016\/j.drugpo.2015.07.003_bib0470","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0475","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis C virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1016\/j.drugpo.2015.07.003_bib0480","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0485","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.20196","article-title":"Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial","volume":"39","author":"Nomura","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0490","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jhep.2001.22112","article-title":"Acute hepatitis C","volume":"33","author":"Orland","year":"2001","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.003_bib0495","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2013.109309","article-title":"Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: A randomized clinical trial","volume":"310","author":"Osinusi","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.003_bib0500","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"Journal of Infectious Diseases"},{"issue":"21","key":"10.1016\/j.drugpo.2015.07.003_bib0505","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0510","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1360-0443.2011.03765.x","article-title":"Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment","volume":"107","author":"Pouget","year":"2012","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.drugpo.2015.07.003_bib0515","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/00007890-199712270-00026","article-title":"Serologic responses to hepatitis C virus in solid organ transplant recipients","volume":"64","author":"Preiksaitis","year":"1997","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0520","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0962280208094689","article-title":"Modelling and calibration of the hepatitis C epidemic in Australia","volume":"18","author":"Razali","year":"2009","journal-title":"Statistical Methods in Medical Research"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2015.07.003_bib0525","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/cit302","article-title":"Recommendations for the management of hepatitis C virus infection among people who inject drugs","volume":"57","author":"Robaeys","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0530","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1746.2003.03270.x","article-title":"Surveillance for newly acquired hepatitis C in Australia","volume":"19","author":"Robotin","year":"2004","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0535","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/OLQ.0b013e31827fd4d4","article-title":"Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China","volume":"40","author":"Ruan","year":"2013","journal-title":"Sexually Transmitted Diseases"},{"issue":"11","key":"10.1016\/j.drugpo.2015.07.003_bib0540","doi-asserted-by":"crossref","first-page":"e80216","DOI":"10.1371\/journal.pone.0080216","article-title":"High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: A prospective cohort study","volume":"8","author":"Sacks-Davis","year":"2013","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0545","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/hep.26991","article-title":"Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin","volume":"59","author":"Santantonio","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0550","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2004.11.021","article-title":"Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance","volume":"42","author":"Santantonio","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0555","doi-asserted-by":"crossref","first-page":"e17781","DOI":"10.1371\/journal.pone.0017781","article-title":"Trouble with bleeding: Risk factors for acute hepatitis C among HIV-positive gay men from Germany \u2013 A case-control study","volume":"6","author":"Schmidt","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.003_bib0560","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000084597","article-title":"Prolonged time until seroconversion among hemodialysis patients: The need for HCV PCR","volume":"48","author":"Schroeter","year":"2005","journal-title":"Intervirology"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.003_bib0565","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7326\/0003-4819-157-8-201210160-00006","article-title":"Accuracy of rapid and point-of-care screening tests for hepatitis C: A systematic review and meta-analysis","volume":"157","author":"Shivkumar","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2015.07.003_bib0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jgh.12677","article-title":"Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia","volume":"29","author":"Sievert","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0575","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/infdis\/jir422","article-title":"Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus","volume":"204","author":"Smith","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.003_bib0580","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/cid\/cir499","article-title":"Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites","volume":"53","author":"Smith","year":"2011","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0585","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/1471-2458-14-830","article-title":"Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs","volume":"14","author":"Snow","year":"2014","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.drugpo.2015.07.003_bib0590","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/592171","article-title":"Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe","volume":"198","author":"Soriano","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"14","key":"10.1016\/j.drugpo.2015.07.003_bib0595","first-page":"309","article-title":"Rapid hepatitis C testing among persons at increased risk for infection \u2013 Wisconsin, 2012\u20132013","volume":"63","author":"Stockman","year":"2014","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.003_bib0600","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0605","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/1471-2458-10-633","article-title":"Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort","volume":"10","author":"Teutsch","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0610","series-title":"HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2014. Sydney NSW 2052","author":"The Kirby Institute","year":"2014"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0615","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0620","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","article-title":"Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men","volume":"60","author":"Thomson","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0625","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0630","doi-asserted-by":"crossref","first-page":"e004988","DOI":"10.1136\/bmjopen-2014-004988","article-title":"Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: A prospective analysis from the UFO Study cohort","volume":"4","author":"Tracy","year":"2014","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.drugpo.2015.07.003_bib0635","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2015.07.003_bib0640","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: Pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.003_bib0645","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0650","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10654-006-9089-7","article-title":"Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users","volume":"22","author":"van den Berg","year":"2007","journal-title":"European Journal of Epidemiology"},{"key":"10.1016\/j.drugpo.2015.07.003_bib0655","first-page":"147","article-title":"Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV","volume":"213C","author":"Vanhommerig","year":"2014","journal-title":"Journal of Virological Methods"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.003_bib0660","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/cid\/cis694","article-title":"Hepatitis C virus infections in the Swiss HIV Cohort Study: A rapidly evolving epidemic","volume":"55","author":"Wandeler","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"4 Suppl. 3","key":"10.1016\/j.drugpo.2015.07.003_bib0665","doi-asserted-by":"crossref","first-page":"19591","DOI":"10.7448\/IAS.17.4.19591","article-title":"Should we offer routine hepatitis C antibody testing in men who have sex with men?","volume":"17","author":"Ward","year":"2014","journal-title":"Journal of the International AIDS Society"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0670","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0956462412472317","article-title":"Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and ribavirin","volume":"24","author":"Webster","year":"2013","journal-title":"International Journal of STD and AIDS"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.003_bib0675","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5694\/mja13.00153","article-title":"Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study","volume":"201","author":"White","year":"2014","journal-title":"Medical Journal of Australia"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.003_bib0680","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.003_bib0685","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archinternmed.2010.511","article-title":"Incidence and transmission patterns of acute hepatitis C in the United States, 1982\u20132006","volume":"171","author":"Williams","year":"2011","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.003_bib0690","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jgh.12355","article-title":"Targeted hepatitis C screening among ex-injection drug users in the community","volume":"29","author":"Wong","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"7","key":"10.1016\/j.drugpo.2015.07.003_bib0695","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/sextrans-2012-050566","article-title":"Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: A systematic review","volume":"88","author":"Yaphe","year":"2012","journal-title":"Sexually Transmitted Infections"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915002042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915002042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T07:12:22Z","timestamp":1652857942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395915002042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":139,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0955395915002042"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.07.003","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the detection and management of acute hepatitis C virus infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}